These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37637426)

  • 21. Contribution of cuproptosis and Cu metabolism-associated genes to chronic obstructive pulmonary disease.
    Qi W; Liu L; Zeng Q; Zhou Z; Chen D; He B; Gong S; Gao L; Wang X; Xiong J; Cai D; Yu S; Zhao L
    J Cell Mol Med; 2023 Dec; 27(24):4034-4044. PubMed ID: 37801050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
    Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
    Liu X; Luo B; Wu X; Tang Z
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
    Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
    J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper and cuproptosis: new therapeutic approaches for Alzheimer's disease.
    Li X; Chen X; Gao X
    Front Aging Neurosci; 2023; 15():1300405. PubMed ID: 38178962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cuproptosis and Cuproptosis-Based Synergistic Therapy for Cancer Treatment.
    Shen Z; Qiu Y; Ding H; Ren F; Chen H
    ChemMedChem; 2024 Jun; ():e202400216. PubMed ID: 38943463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma.
    Lei G; Tang L; Yu Y; Bian W; Yu L; Zhou J; Li Y; Wang Y; Du J
    Biomed Pharmacother; 2023 Nov; 167():115522. PubMed ID: 37757497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.
    Song W; Yue Y; Zhang Q; Wang X
    Front Physiol; 2024; 15():1243629. PubMed ID: 38883186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cuproptosis in cancer: biological implications and therapeutic opportunities.
    Li L; Zhou H; Zhang C
    Cell Mol Biol Lett; 2024 Jun; 29(1):91. PubMed ID: 38918694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
    Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
    Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis-a potential target for the treatment of osteoporosis.
    Li D; Gao Z; Li Q; Liu X; Liu H
    Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
    Peng TE; Qiu F; Qu Y; Yu C; Cheng X; Li L
    ChemistryOpen; 2023 Sep; 12(9):e202300078. PubMed ID: 37705070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
    Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
    Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
    Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
    Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies.
    Chen X; Cai Q; Liang R; Zhang D; Liu X; Zhang M; Xiong Y; Xu M; Liu Q; Li P; Yu P; Shi A
    Cell Death Dis; 2023 Feb; 14(2):105. PubMed ID: 36774340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
    Zhao Q; Qi T
    Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cinobufagin treatments suppress tumor growth by enhancing the expression of cuproptosis-related genes in liver cancer.
    AmeliMojarad M; AmeliMojarad M; Shariati P
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; ():. PubMed ID: 39120719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cuproptosis in cancers: Function and implications from bench to bedside.
    Huang XY; Shen JY; Huang K; Wang L; Sethi G; Ma Z
    Biomed Pharmacother; 2024 Jul; 176():116874. PubMed ID: 38850661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.